This week's set of innovators to know are making waves in industries across Houston. Courtesy photos

In this Monday roundup of Houston innovators, we traverse into the restaurant, health care, and higher education industries with a startup founder focused on using technology to improve the dining experience, a self-starter in health care, and a leader on the Rice University campus with a new office for his growing staff.

Brad Burke, managing director of the Rice Alliance for Technology and Entrepreneurship

Photo via alliance.rice.edu

The Rice Alliance for Technology and Entrepreneurship has moved into its new Gensler-designed, 3,000-square-foot Bill and Stephanie Sick Suite that is expected to be a game changer for the program.

"The Rice Alliance meets frequently with venture capitalists, entrepreneurs, students, mentors, and other members of the Houston entrepreneurial ecosystem," says Brad Burke, who leads the innovation arm of Rice University. "The new space is on the first floor of the Jones School and is much more accessible and visible to our guests and visitors." Click here to read more and see photos of the space.

Roberta Schwartz, executive vice president and chief innovation officer at Houston Methodist

Courtesy of Houston Methodist

Roberta Schwartz is an innovator by nature. On last week's episode of the Houston Innovators Podcast, she shared her story of overcoming breast cancer as a young woman. Seeking a support system and camaraderie, she co-founded the Young Survival Coalition.

"I was 27 when I was unexpectedly diagnosed with breast cancer — I have no family history, no cancer in the family. It certainly was a shock to my system," Schwartz says on this week's episode of the Houston Innovators Podcast. "Once I was diagnosed, and through some of the original surgery and care I had to do, I knew that I wanted to reach out and find a larger community of young women."

Now, she's leading Houston Methodist's Center for Innovation, another entity she saw a need for, then created. Click here to read the story and stream the podcast episode.

Ken Bridge, founder of Roovy Technologies

Photo courtesy of Roovy

People use their smartphones for everything these days. So, Houston restaurateur Ken Bridge thought, why couldn't they use them to optimize their dining experience? Bridge created Roovy Technologies, and the app uses point-of-sale technology to put the power of ordering, paying, and communicating with the kitchen and bar, right into the hands of customers.

"Roovy is a platform that allows the user to order and pay entirely from their phone," says Bridge. "We will soon be the first company to have all three categories of this type of app: dine-in, take out and delivery." Click here to read more about Roovy.

Houston-based Roovy Technologies has created a mobile app where people can control their dining experience completely from their phones. Photo via roovy.io

Growing Houston startup is digitizing the dining experience

Digital dinner

Imagine going into a popular restaurant, sitting down at an open table and controlling the entire dining experience from a smartphone.

That's food, drinks, and even dessert all ordered and paid for on a phone.

Prolific Houston-area restaurateur Ken Bridge had the vision to converge dining with technology by creating a digital solution to combat chronic wait times in restaurants.

That vision became the Roovy Technologies mobile app, a platform designed to create the ultimate convenience for gastronauts everywhere.

"Roovy was birthed out of frustration," says Bridge, the serial entrepreneur behind the Delicious Concepts restaurant group. "Years ago, we would typically have lines out the door, so I thought to myself, that with technology, there should be a way for a guest to come in and manage their experience entirely from their phone.

"I felt like guests could go in, get sat at a table and order their food from their phone and pay from their phone and call it a day. That's how the idea of Roovy was conceived."

Three years ago, after putting mock pages together, Bridge started attending South by Southwest Interactive in Austin for research and inspiration. That led to commissioning a local boutique development agency in Houston to build out Roovy's Minimum Viable Product or road map before creating a fully functional platform.

"Roovy is a platform that allows the user to order and pay entirely from their phone," says Bridge. "We will soon be the first company to have all three categories of this type of app: dine-in, take out and delivery."

Bridge deployed Roovy in his Japanese concept restaurant, Blackbird Izakaya, at 1221 W. 11th St. in the Heights several months ago to test out the app before rolling it out to several other restaurants.

"It's a work in progress like everything else," says Bridge, who hopes for Roovy to be deployed in 20 restaurants very soon, then 40. "Everyday we're going to have issues that we need to resolve. But for now, we'll build it, we'll test it, we'll learn and we'll continue to go back and work out the kinks and keep pushing forward from there."

Convenience — on both sides of the transaction

For users, the value proposition is to be able to order and pay from their phone.

"Even a really good server can be impeding at the same time, over-qualifying or checking too much on a table that it becomes a distraction," says Bridge. "With Roovy, when the user is ready to order they can. It's convenience-based technology."

For operators, it streamlines the entire process, up to and including payment.

"We built this as a native solution, so restaurants can technically operate their entire restaurant on one single iPad, while cutting out all hardware," says Bridge.

The restaurant's menu is fully interactive and constantly updated in the app.

When a user places an order, they can add notes to alert the kitchen or bar with their allergies or substitutions and the kitchen or bar receives the notice on the Kitchen Display Side.

That order is then colored and timed, depending on the restaurant's flow and the user then receives a page when the order is ready.

"When restaurant's not packed, they can prepare orders in four minutes, but when packed, it may take eight minutes," says Bridge. "So through the machine learning, they can input a flow time, but then the system intuitively will become more and more intelligent based on the number of tickets and how frequently the operator is stocking and selling a particular item."

Bridge funded Roovy with his own money, so running the cloud-based platform in his own restaurants provided another distinct advantage for his startup's bottom line. And, with operators running the Roovy platform, it has officially entered post-revenue valuation. Roovy's revenue, like other payments facilitators, comes from its restaurant clients.

With the method of payment tied into the app, users pay from their phone and Roovy processes that payment transaction between the user, operator and bank tied to that payment method for a processing fee, much like a point-of-sale provider would with traditional POS devices.

Increasing opportunities for sales

What separates Roovy from other processors, though, is more than just the disruption of bulky hardware, printers and other equipment that can be very expensive for the operator.

It's the ability to maximize sales through convenience.

Case in point: in a busy restaurant, customers who have finished their meal, but possibly have cravings for another drink or a dessert might choose to eschew the urge based on the availability of their wait staff or the line at the bar.

But with Roovy, they could simply add the additional food item or drink to their cart, and have it at their table in no time.

"A lot of restaurants are not taking advantage of opportunities to maximize their sales," says Bridge. "If the per person average for a particular restaurant is $20, the likelihood that there are customers that want one more beer but don't want to go through the motions of ordering it based on service not being around is high. They're going to just leave and the restaurant just missed out on a potential $6.

"That would have been a 30 percent increase in sales," Bridge continues. "So, because of Roovy's ease of use, restaurants can increase their per person revenue and we guarantee an increase of 19 or 20 percent for operators that use our platform."

An additional revenue stream for Roovy centers on its pinpointed marketing campaigns designed to push promotions to its users based on user data and analytics.

"We can help operators run promotions for our users that can be very specific to the demographic of their choice," says Bridge. "They can be very direct and specific push notifications that go out to users based on location, vicinity or proximity, for example. We could also push notifications to a restaurant's repeat customers."

More features to come

For users that want take out, Roovy will be working with predictive arrival technology to estimate better execution times for orders so that they will be as fresh as possible for customer pickup.

Roovy will also be adding "Roovy Coin," a loyalty and rewards programs, as well as a social component for those users that like to share their experience with their friends.

"Beyond this super unique emerging technology, we are building heavily on the sociability aspects of it," says Bridge. "For example, users will be able to check in with friends, plan potential meetups, share video clips with their friends and the community on the platform and be able to review restaurants.

"I kid about this all the time, but most of us remember two things: the first kiss we had and the first time we used Uber. We'll never forget that. Our goal is to come in with that same kind of impact and convince users and operators that Roovy is not just a great technology, it's the inevitable technology that will be adopted on mass levels."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.